Wordt geladen...
CSF biomarkers for Alzheimer disease — approaching consensus
A European working group has provided a new set of recommendations for the use of cerebrospinal fluid (CSF) biomarkers in the diagnostic evaluation of Alzheimer disease and mild cognitive impairment. These recommendations represent an important step towards the implementation of CSF biomarker tests...
Bewaard in:
| Gepubliceerd in: | Nat Rev Neurol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5912691/ https://ncbi.nlm.nih.gov/pubmed/28155892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneurol.2017.11 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|